A genetic model for neurodevelopmental disease

Current Opinion in Neurobiology

Volumn 22, Issue 5, 2012, Pages 829-836

  Coe, Bradley P ^a   Girirajan, Santhosh ^a   Eichler, Evan E ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC PROCEDURES; HUMAN; MENTAL DISEASE; NEURODEVELOPMENTAL DISEASE; NEUROLOGIC DISEASE; NEUROPSYCHIATRIC DISEASE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; REVIEW;

ANIMALS; DEVELOPMENTAL DISABILITIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MODELS, GENETIC; NERVOUS SYSTEM DISEASES;

EID: 84868215533     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2012.04.007     Document Type: Review

References (67)

1. Cooper G.M., Coe B.P., Girirajan S., Rosenfeld J.A., Vu T.H., Baker C., Williams C., Stalker H., Hamid R., Hannig V., et al. A copy number variation morbidity map of developmental delay. Nature Genetics 2011, 43:838-846.
2. Kaminsky E.B., Kaul V., Paschall J., Church D.M., Bunke B., Kunig D., Moreno-De-Luca D., Moreno-De-Luca A., Mulle J.G., Warren S.T., et al. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. Genetics in Medicine 2011, 13:777-784.
3. Ropers H.H. Genetics of early onset cognitive impairment. Annual Review of Genomics and Human Genetics 2010, 11:161-187.
4. The 1000 Genomes Project Consortium: a map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073.
5. Camerino G., Mattei M.G., Mattei J.F., Jaye M., Mandel J.L. Close linkage of fragile X-mental retardation syndrome to haemophilia B and transmission through a normal male. Nature 1983, 306:701-704.
6. Ewart A.K., Morris C.A., Atkinson D., Jin W., Sternes K., Spallone P., Stock A.D., Leppert M., Keating M.T. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nature Genetics 1993, 5:11-16.
7. Ledbetter D.H., Riccardi V.M., Airhart S.D., Strobel R.J., Keenan B.S., Crawford J.D. Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. New England Journal of Medicine 1981, 304:325-329.
8. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., Devon R.S., St Clair D.M., Muir W.J., Blackwood D.H., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Human Molecular Genetics 2000, 9:1415-1423.
9. Ottman R., Risch N., Hauser W.A., Pedley T.A., Lee J.H., Barker-Cummings C., Lustenberger A., Nagle K.J., Lee K.S., Scheuer M.L., et al. Localization of a gene for partial epilepsy to chromosome 10q. Nature Genetics 1995, 10:56-60.
10. Manolio T.A., Collins F.S., Cox N.J., Goldstein D.B., Hindorff L.A., Hunter D.J., McCarthy M.I., Ramos E.M., Cardon L.R., Chakravarti A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
11. Mefford H.C., Muhle H., Ostertag P., von Spiczak S., Buysse K., Baker C., Franke A., Malafosse A., Genton P., Thomas P., et al. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genetics 2010, 6:e1000962.
12. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
13. de Vries B.B., Pfundt R., Leisink M., Koolen D.A., Vissers L.E., Janssen I.M., Reijmersdal S., Nillesen W.M., Huys E.H., Leeuw N., et al. Diagnostic genome profiling in mental retardation. American Journal of Human Genetics 2005, 77:606-616.
14. Sharp A.J., Hansen S., Selzer R.R., Cheng Z., Regan R., Hurst J.A., Stewart H., Price S.M., Blair E., Hennekam R.C., et al. Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome. Nature Genetics 2006, 38:1038-1042.
15. Sebat J., Lakshmi B., Malhotra D., Troge J., Lese-Martin C., Walsh T., Yamrom B., Yoon S., Krasnitz A., Kendall J., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
16. Bailey J.A., Gu Z., Clark R.A., Reinert K., Samonte R.V., Schwartz S., Adams M.D., Myers E.W., Li P.W., Eichler E.E. Recent segmental duplications in the human genome. Science 2002, 297:1003-1007.
17. Stankiewicz P., Lupski J.R. Structural variation in the human genome and its role in disease. Annual Review of Medicine 2010, 61:437-455.
18. Hochstenbach R., Buizer-Voskamp J.E., Vorstman J.A., Ophoff R.A. Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research. Cytogenetic and Genome Research 2011, 135:174-202.
19. Girirajan S., Brkanac Z., Coe B.P., Baker C., Vives L., Vu T.H., Shafer N., Bernier R., Ferrero G.B., Silengo M., et al. Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genetics 2011, 7:e1002334.
20. Girirajan S., Eichler E.E. De novo CNVs in bipolar disorder: recurrent themes or new directions?. Neuron 2011, 72:885-887.
21. Pinto D., Pagnamenta A.T., Klei L., Anney R., Merico D., Regan R., Conroy J., Magalhaes T.R., Correia C., Abrahams B.S., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
22. Sanders S.J., Ercan-Sencicek A.G., Hus V., Luo R., Murtha M.T., Moreno-De-Luca D., Chu S.H., Moreau M.P., Gupta A.R., Thomson S.A., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
23. The International Schizophrenia Consortium: rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455:237-241.
24. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., Fossdal R., Sigurdsson E., Sigmundsson T., Buizer-Voskamp J.E., et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455:232-236.
25. Grozeva D., Kirov G., Ivanov D., Jones I.R., Jones L., Green E.K., St Clair D.M., Young A.H., Ferrier N., Farmer A.E., et al. Rare copy number variants: a point of rarity in genetic risk for bipolar disorder and schizophrenia. Archives of General Psychiatry 2010, 67:318-327.
26. Malhotra D., McCarthy S., Michaelson J.J., Vacic V., Burdick K.E., Yoon S., Cichon S., Corvin A., Gary S., Gershon E.S., et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011, 72:951-963.
27. Fernandez T.V., Sanders S.J., Yurkiewicz I.R., Ercan-Sencicek A.G., Kim Y.S., Fishman D.O., Raubeson M.J., Song Y., Yasuno K., Ho W.S., et al. Rare copy number variants in tourette syndrome disrupt genes in histaminergic pathways and overlap with autism. Biological Psychiatry 2011.
28. Itsara A., Wu H., Smith J.D., Nickerson D.A., Romieu I., London S.J., Eichler E.E. De novo rates and selection of large copy number variation. Genome Research 2010, 20:1469-1481.
29. Sudmant P.H., Kitzman J.O., Antonacci F., Alkan C., Malig M., Tsalenko A., Sampas N., Bruhn L., Shendure J., Eichler E.E. Diversity of human copy number variation and multicopy genes. Science 2010, 330:641-646.
30. Alkan C., Coe B.P., Eichler E.E. Genome structural variation discovery and genotyping. Nature Reviews Genetics 2011, 12:363-376.
31. Hormozdiari F., Alkan C., Eichler E.E., Sahinalp S.C. Combinatorial algorithms for structural variation detection in high-throughput sequenced genomes. Genome Research 2009, 19:1270-1278.
32. Qi J., Zhao F. inGAP-sv: a novel scheme to identify and visualize structural variation from paired end mapping data. Nucleic Acids Research 2011, 39:W567-W575.
33. Zhang J., Wu Y. SVseq: an approach for detecting exact breakpoints of deletions with low-coverage sequence data. Bioinformatics 2011, 27:3228-3234.
34. Campbell P.J., Stephens P.J., Pleasance E.D., O'Meara S., Li H., Santarius T., Stebbings L.A., Leroy C., Edkins S., Hardy C., et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nature Genetics 2008, 40:722-729.
35. Xi R., Hadjipanayis A.G., Luquette L.J., Kim T.M., Lee E., Zhang J., Johnson M.D., Muzny D.M., Wheeler D.A., Gibbs R.A., et al. Copy number variation detection in whole-genome sequencing data using the Bayesian information criterion. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:E1128-E1136.
36. Yoon S., Xuan Z., Makarov V., Ye K., Sebat J. Sensitive and accurate detection of copy number variants using read depth of coverage. Genome Research 2009, 19:1586-1592.
37. Zhang Z.D., Gerstein M.B. Detection of copy number variation from array intensity and sequencing read depth using a stepwise Bayesian model. BMC Bioinformatics 2010, 11:539.
38. Najmabadi H., Hu H., Garshasbi M., Zemojtel T., Abedini S.S., Chen W., Hosseini M., Behjati F., Haas S., Jamali P., et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011, 478:57-63.
39. O'Roak B.J., Deriziotis P., Lee C., Vives L., Schwartz J.J., Girirajan S., Karakoc E., Mackenzie A.P., Ng S.B., Baker C., et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nature Genetics 2011, 43:585-589.
40. Karakoc E., Alkan C., O'Roak B.J., Dennis M.Y., Vives L., Mark K., Rieder M.J., Nickerson D.A., Eichler E.E. Detection of structural variants and indels within exome data. Nature Methods 2011.
41. Sathirapongsasuti J.F., Lee H., Horst B.A., Brunner G., Cochran A.J., Binder S., Quackenbush J., Nelson S.F. Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV. Bioinformatics 2011, 27:2648-2654.
42. Behnecke A., Hinderhofer K., Bartsch O., Numann A., Ipach M.L., Damatova N., Haaf T., Dufke A., Riess O., Moog U. Intragenic deletions of IL1RAPL1: report of two cases and review of the literature. American Journal of Medical Genetics A 2011, 155A:372-379.
43. Boone P.M., Bacino C.A., Shaw C.A., Eng P.A., Hixson P.M., Pursley A.N., Kang S.H., Yang Y., Wiszniewska J., Nowakowska B.A., et al. Detection of clinically relevant exonic copy-number changes by array CGH. Human Mutation 2010, 31:1326-1342.
44. Celestino-Soper P.B., Shaw C.A., Sanders S.J., Li J., Murtha M.T., Ercan-Sencicek A.G., Davis L., Thomson S., Gambin T., Chinault A.C., et al. Use of array CGH to detect exonic copy number variants throughout the genome in autism families detects a novel deletion in TMLHE. Human Molecular Genetics 2011, 20:4360-4370.
45. Mikhail F.M., Lose E.J., Robin N.H., Descartes M.D., Rutledge K.D., Rutledge S.L., Korf B.R., Carroll A.J. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders. American Journal of Medical Genetics A 2011, 155A:2386-2396.
46. Miller D.T., Adam M.P., Aradhya S., Biesecker L.G., Brothman A.R., Carter N.P., Church D.M., Crolla J.A., Eichler E.E., Epstein C.J., et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics 2010, 86:749-764.
47. Levinson D.F., Duan J., Oh S., Wang K., Sanders A.R., Shi J., Zhang N., Mowry B.J., Olincy A., Amin F., et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. American Journal of Psychiatry 2011, 168:302-316.
48. Vacic V., McCarthy S., Malhotra D., Murray F., Chou H.H., Peoples A., Makarov V., Yoon S., Bhandari A., Corominas R., et al. Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 2011, 471:499-503.
49. Crepel A., Steyaert J., De la Marche W., De Wolf V., Fryns J.P., Noens I., Devriendt K., Peeters H. Narrowing the critical deletion region for autism spectrum disorders on 16p11.2. American Journal of Medical Genetics B: Neuropsychiatric Gentics 2011, 156:243-245.
50. Konyukh M., Delorme R., Chaste P., Leblond C., Lemiere N., Nygren G., Anckarsater H., Rastam M., Stahlberg O., Amsellem F., et al. Variations of the candidate SEZ6L2 gene on chromosome 16p11.2 in patients with autism spectrum disorders and in human populations. PLoS ONE 2011, 6:e17289.
51. Kumar R.A., KaraMohamed S., Sudi J., Conrad D.F., Brune C., Badner J.A., Gilliam T.C., Nowak N.J., Cook E.H., Dobyns W.B., et al. Recurrent 16p11.2 microdeletions in autism. Human Molecular Genetics 2008, 17:628-638.
52. O'Roak B.J., Vives L., Girirajan S., Karakoc E., Krumm N., Coe B.P., Levy R., Ko A., Lee C., Smith J., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, [Epub ahead of print]. 10.1038/nature10989.
53. Talkowski M.E., Mullegama S.V., Rosenfeld J.A., van Bon B.W., Shen Y., Repnikova E.A., Gastier-Foster J., Thrush D.L., Kathiresan S., Ruderfer D.M., et al. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. American Journal of Human Genetics 2011, 89:551-563.
54. van Bon B.W., Koolen D.A., Brueton L., McMullan D., Lichtenbelt K.D., Ades L.C., Peters G., Gibson K., Moloney S., Novara F., et al. The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype. European Journal of Human Genetics 2010, 18:163-170.
55. Williams S.R., Mullegama S.V., Rosenfeld J.A., Dagli A.I., Hatchwell E., Allen W.P., Williams C.A., Elsea S.H. Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures. European Journal of Human Genetics 2010, 18:436-441.
56. Dibbens L.M., Mullen S., Helbig I., Mefford H.C., Bayly M.A., Bellows S., Leu C., Trucks H., Obermeier T., Wittig M., et al. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Human Molecular Genetics 2009, 18:3626-3631.
57. Helbig I., Mefford H.C., Sharp A.J., Guipponi M., Fichera M., Franke A., Muhle H., de Kovel C., Baker C., von Spiczak S., et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nature Genetics 2009, 41:160-162.
58. Marshall C.R., Noor A., Vincent J.B., Lionel A.C., Feuk L., Skaug J., Shago M., Moessner R., Pinto D., Ren Y., et al. Structural variation of chromosomes in autism spectrum disorder. American Journal of Human Genetics 2008, 82:477-488.
59. Sharp A.J., Mefford H.C., Li K., Baker C., Skinner C., Stevenson R.E., Schroer R.J., Novara F., De Gregori M., Ciccone R., et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nature Genetics 2008, 40:322-328.
60. Girirajan S., Rosenfeld J.A., Cooper G.M., Antonacci F., Siswara P., Itsara A., Vives L., Walsh T., McCarthy S.E., Baker C., et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nature Genetics 2010, 42:203-209.
61. Schaaf C.P., Sabo A., Sakai Y., Crosby J., Muzny D., Hawes A., Lewis L., Akbar H., Varghese R., Boerwinkle E., et al. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Human Molecular Genetics 2011, 20:3366-3375.
62. Auerbach B.D., Osterweil E.K., Bear M.F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 2011, 480:63-68.
63. Kirov G., Pocklington A.J., Holmans P., Ivanov D., Ikeda M., Ruderfer D., Moran J., Chambert K., Toncheva D., Georgieva L., et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Molecular Psychiatry 2011.
64. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 1987, 44:660-669.
65. Gilman S.R., Iossifov I., Levy D., Ronemus M., Wigler M., Vitkup D. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 2011, 70:898-907.
66. Zoghbi H.Y. Postnatal neurodevelopmental disorders: meeting at the synapse?. Science 2003, 302:826-830.
67. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., Mill J., Cantor R.M., Blencowe B.J., Geschwind D.H. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.